Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
J Acquir Immune Defic Syndr ; 95(4): 329-341, 2024 04 01.
Artigo em Inglês | MEDLINE | ID: mdl-38133577

RESUMO

BACKGROUND: Racial/ethnic minority groups with HIV in the United States are particularly vulnerable to COVID-19 consequences and can significantly benefit from increased uptake of COVID-19 vaccines. This study identified factors associated with full COVID-19 vaccination among people with HIV. SETTING: Ryan White HIV/AIDS Program in Miami-Dade County, FL. METHODS: Data were collected from 299 Ryan White HIV/AIDS Program adult clients during January-March 2022 using a cross-sectional phone survey. Multivariable logistic regression was used to estimate adjusted odds ratios (aORs) with 95% confidence intervals (CIs). All analyses were weighted to be representative of the race/ethnicity and sex distribution of clients in the Ryan White HIV/AIDS Program. RESULTS: Eighty-four percent of participants were fully vaccinated with a primary vaccine series; stratified by race/ethnicity, the percentages were 88.9% of Hispanic, 72.0% of black/African American, and 67.5% of Haitian participants. Fully vaccinated participants were less likely to be black/African American than Hispanic (aOR = 0.18; 95% CI: 0.05 to 0.67) and more likely to not endorse any misconceptions about COVID-19 vaccines (aOR = 8.26; 95% CI: 1.38 to 49.64), to report encouragement to get vaccinated from sources of information (aOR = 20.82; 95% CI: 5.84 to 74.14), and to perceive that more than 50% of their social network was vaccinated (aOR = 3.35; 95% CI: 1.04 to 10.71). Experiences of health care discrimination, structural barriers to access vaccines, and recommendations from HIV providers were not associated with full vaccination. CONCLUSIONS: These findings highlight the importance of delivering accurate and positive messages about vaccines and engaging social networks to promote COVID-19 vaccination among people with HIV. This information can be leveraged to promote uptake of subsequent boosters and other recommended vaccines.


Assuntos
Síndrome da Imunodeficiência Adquirida , COVID-19 , Infecções por HIV , Adulto , Humanos , Estados Unidos , Etnicidade , Florida/epidemiologia , Vacinas contra COVID-19 , Minorias Étnicas e Raciais , Estudos Transversais , Haiti , COVID-19/epidemiologia , COVID-19/prevenção & controle , Grupos Minoritários , Infecções por HIV/epidemiologia , Infecções por HIV/prevenção & controle , Vacinação , Brancos
3.
Am J Infect Control ; 47(12): 1500-1504, 2019 12.
Artigo em Inglês | MEDLINE | ID: mdl-31324490

RESUMO

BACKGROUND: Hospital-acquired infections (HAIs) lead to poor health outcomes in hospitalized patients and may be disproportionately affecting the aging population of people living with HIV (PLWH). This study determined the association between HIV and HAIs, and analyzed the potential mediating effects of comorbidities. METHODS: The Louisiana Hospital Inpatient Discharge Database for the years 2011-2015 was used. All patients with at least 1 HAI diagnosis within this source population were included as cases in the case-control study, and a 1:1 ratio of controls was randomly selected from the same hospitals. RESULTS: Of the 1,852,769 eligible hospital discharges that occurred from 2011 through 2015, there were 7,422 patients with at least 1 HAI. Marginal logistic regressions of the case-control sample showed a strong association between HIV and central line-associated bloodstream infections (CLABSIs), but an inverse association between HIV and any HAI. However, the mediation analyses revealed that having at least 1 comorbidity mediates the association between HIV and CLABSIs. DISCUSSION: The unexpected inverse association between HIV and HAI could be attributed to the sample size of the exposed group of patients, or it could be explained by the mechanisms of treatment for HIV patients. CONCLUSIONS: This study found that people living with HIV are at an increased risk of developing a CLABSI, which is consistent with the published literature. The mediation analyses indicated that having at least 1 comorbidity mediated the association between HIV and CLABSI diagnosis.


Assuntos
Doenças Cardiovasculares/epidemiologia , Infecções Relacionadas a Cateter/epidemiologia , Infecção Hospitalar/epidemiologia , Diabetes Mellitus/epidemiologia , Infecções por HIV/epidemiologia , Nefropatias/epidemiologia , Hepatopatias/epidemiologia , Neoplasias/epidemiologia , Adulto , Idoso , Doenças Cardiovasculares/microbiologia , Doenças Cardiovasculares/virologia , Estudos de Casos e Controles , Infecções Relacionadas a Cateter/microbiologia , Infecções Relacionadas a Cateter/virologia , Comorbidade , Infecção Hospitalar/microbiologia , Infecção Hospitalar/virologia , Bases de Dados Factuais , Diabetes Mellitus/microbiologia , Diabetes Mellitus/virologia , Feminino , Infecções por HIV/microbiologia , Infecções por HIV/virologia , Humanos , Nefropatias/microbiologia , Nefropatias/virologia , Hepatopatias/microbiologia , Hepatopatias/virologia , Modelos Logísticos , Louisiana/epidemiologia , Masculino , Pessoa de Meia-Idade , Neoplasias/microbiologia , Neoplasias/virologia , Tamanho da Amostra
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA